IL20RB and age-related macular degeneration: In the eQTLGen dataset, increased expression of IL20RB was associated with higher risk of AMD (OR = 2.09, 95%CI: 1.74–2.84, p = 1.61E-02) and Dry AMD (OR = 2.31, 95%CI: 1.14–4.66, p = 2.01E-02), while expression of WARS1 was associated with decreased risk of AMD (OR = 0.90, 95%CI: 0.86–0.95, p = 4.42E-05), Dry AMD (OR = 0.91, 95%CI: 0.85–0.96, p = 1.94E-03), and Wet AMD (OR = 0.89, 95%CI: 0.83–0.95, p = 9.06E-04).